EpiPen's Dominance Driven By Competitors' Stumbles And Tragic Deaths
The company's lobbying of state legislatures is just one factor in EpiPen's dominance of the market. Manufacturers of competing devices have struggled to gain a foothold.
Read more on NPR
No comments:
Post a Comment